Opus Capital Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,171
Closed -$1.02M 175
2019
Q1
$1.02M Sell
10,171
-14,744
-59% -$1.32M 0.27% 55
2018
Q4
$2.03M Buy
24,915
+481
+2% +$43.7K 0.42% 45
2018
Q3
$2.41M Sell
24,434
-276
-1% -$29.2K 0.54% 40
2018
Q2
$2.68M Sell
24,710
-35
-0.1% -$3.76K 0.66% 22
2018
Q1
$2.58M Sell
24,745
-8,078
-25% -$939K 0.65% 22
2017
Q4
$3.86M Sell
32,823
-3,923
-11% -$406K 0.85% 14
2017
Q3
$3.63M Sell
36,746
-11,217
-23% -$999K 0.83% 22
2017
Q2
$4.27M Buy
47,963
+43,867
+1,071% +$3.86M 0.84% 28
2017
Q1
$367K Buy
4,096
+28
+0.7% +$2.41K 0.05% 170
2016
Q4
$351K Buy
+4,068
New +$363K 0.05% 164

Other funds holding CRI

Opus Capital Group's CRI Position: Q2 2019 in Review

Opus Capital Group sold out of Carter's (CRI) in Q2 2019, closing a stake of 10,171 shares — an estimated $1.02M sold.

Opus Capital Group first reported a position in CRI in Q4 2016 and held it in 10 quarters. The position peaked at $4.27M in Q2 2017. 305 funds tracked by Wall St. Rank hold CRI as of Q2 2019.

  • Opus Capital Group reported no remaining Carter's position as of Q2 2019 after selling out during the quarter.
  • Opus Capital Group sold 10,171 Carter's shares in Q2 2019, an estimated $1.02M.
  • Opus Capital Group first reported a position in Carter's in Q4 2016 and held it in 10 quarters.
  • Opus Capital Group's Carter's position peaked at $4.27M in Q2 2017.
  • 305 funds tracked by Wall St. Rank held Carter's as of Q2 2019.

Based on Opus Capital Group's 13F filing for Q2 2019, filed 8 Aug 2019.